Voronoi, Inc. (KOSDAQ:310210)

South Korea flag South Korea · Delayed Price · Currency is KRW
334,500
+21,000 (6.70%)
At close: Feb 27, 2026
195.49%
Market Cap 6.02T
Revenue (ttm) 7.49B
Net Income (ttm) -47.26B
Shares Out 17.99M
EPS (ttm) -2,628.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 133,279
Average Volume 114,849
Open 314,000
Previous Close 313,500
Day's Range 314,000 - 349,000
52-Week Range 89,800 - 349,000
Beta 1.74
RSI 81.14
Earnings Date Feb 13, 2026

About Voronoi

Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company’s products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multipl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 140
Stock Exchange KOSDAQ
Ticker Symbol 310210
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.